Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (17)	6/4/1999 12:53:00 PM
From: scaram(o)uche	Read Replies (3) \| Respond to of 1833

Weird beyond weird. Why, with the company on the auction block and selling at a fraction of book, would someone take 7/16 for a big chunk? Seems like a strange time to try to clear $300-500K out of this sucker. If Pfizer is correct, seems like this is a $3 stock. If Pfizer isn't correct, SIBI is a $20 stock. Since I don't believe that KDUS is worth less than a buck under any circumstance and that SIBI is worth less than $5 under worst case scenario (these are my opinions only, please get your own), I've been playing KDUS at 7/8 as a hedge for a bit of my SIBI. But 7/16? At this late stage? Some biotech funds are in a ton of trouble.